Jean Dausset

Articles in Scholarly Journals [Incomplete List]

  1. Linkage proof for PTPN22, a rheumatoid arthritis susceptibility gene and a human autoimmunity gene
    Proceedings of the National Academy of Sciences, vol. 104, no. 5, pp. 1649–1654, 2007
  2. Potential targets of FOXL2, a transcription factor involved in craniofacial and follicular development, identified by transcriptomics
    Proceedings of the National Academy of Sciences, vol. 104, no. 9, pp. 3330–3335, 2007
  3. Identification of target actin content and polymerization status as a mechanism of tumor resistance after cytolytic T lymphocyte pressure
    Proceedings of the National Academy of Sciences, vol. 103, no. 5, pp. 1428–1433, 2006
  4. In vivo repopulation ability of genetically corrected bone marrow cells from Fanconi anemia patients
    Proceedings of the National Academy of Sciences, vol. 103, no. 7, pp. 2340–2345, 2006
  5. HLA-G1-expressing antigen-presenting cells induce immunosuppressive CD4+ T cells
    Proceedings of the National Academy of Sciences, vol. 101, no. 18, pp. 7064–7069, 2004
  6. Pleiotropic effects of the 8.1 HLA haplotype in patients with autoimmune myasthenia gravis and thymus hyperplasia
    Proceedings of the National Academy of Sciences, vol. 101, no. 43, pp. 15464–15469, 2004
  7. Expression of HLA-G in inflammatory bowel disease provides a potential way to distinguish between ulcerative colitis and Crohn's disease
    International Immunology, vol. 16, no. 4, pp. 579–583, 2004
  8. In vivo, RFX5 binds differently to the human leucocyte antigen-E, -F, and -G gene promoters and participates in HLA class I protein expression in a cell type-dependent manner
    Immunology, vol. 111, no. 1, pp. 53–65, 2004
  9. Alloreactive CD4+ and CD8+ T cells express the immunotolerant HLA-G molecule in mixed lymphocyte reactions:in vivo implications in transplanted patients
    European Journal of Immunology, vol. 34, no. 3, pp. 649–660, 2004
  10. Human leukocyte antigen-G (HLA-G) expression in biliary epithelial cells is associated with allograft acceptance in liver-kidney transplantation
    Journal of Hepatology, vol. 39, no. 4, pp. 587–594, 2003
  11. Progress of HLA-G in cancer
    Seminars in Cancer Biology, vol. 13, no. 5, pp. 315–316, 2003
  12. HLA-G in Transplantation: A Relevant Molecule for Inhibition of Graft Rejection?
    American Journal of Transplantation, vol. 3, no. 1, pp. 11–16, 2003
  13. Human leukocyte antigen–C in short- and long-term liver graft acceptance
    Liver Transplantation, vol. 9, no. 3, pp. 218–227, 2003
  14. HLA-G gene repression is reversed by demethylation
    Proceedings of the National Academy of Sciences, vol. 100, no. 3, pp. 1191–1196, 2003
  15. The p53-inducible TSAP6 gene product regulates apoptosis and the cell cycle and interacts with Nix and the Myt1 kinase
    Proceedings of the National Academy of Sciences, vol. 100, no. 5, pp. 2284–2289, 2003
  16. Viewpoint on the Functionality of the Human Leukocyte Antigen-G Null Allele at the Fetal-Maternal Interface
    Biology of Reproduction, vol. 67, no. 5, pp. 1375–1378, 2002
  17. Aids, vol. 16, no. 3, pp. 347–351, 2002
  18. Human Leukocyte Antigen-G Expression After Heart Transplantation Is Associated With a Reduced Incidence of Rejection
    Circulation, vol. 105, no. 16, pp. 1949–1954, 2002
  19. Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer
    The Journal of Pathology, vol. 196, no. 3, pp. 266–274, 2002
  20. Transplantation and humanism in the new millenium
    Transplantation Proceedings, vol. 33, no. 1-2, pp. 1983–1985, 2001
  21. HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition
    International Immunology, vol. 13, no. 2, pp. 193–201, 2001
  22. Spontaneous retinopathy in HLA-A29 transgenic mice
    Proceedings of the National Academy of Sciences, vol. 98, no. 5, pp. 2572–2576, 2001
  23. The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: Neuropathologic and genetic evidence for a role in Huntington's disease pathogenesis
    Proceedings of the National Academy of Sciences, vol. 98, no. 4, pp. 1811–1816, 2001
  24. Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: A CD4+ T cell regulatory mechanism
    Proceedings of the National Academy of Sciences, vol. 98, no. 21, pp. 12150–12155, 2001
  25. Expanded polyglutamines in Caenorhabditis elegans cause axonal abnormalities and severe dysfunction of PLM mechanosensory neurons without cell death
    Proceedings of the National Academy of Sciences, vol. 98, no. 23, pp. 13318–13323, 2001
  26. A Specific Interferon (IFN)-stimulated Response Element of the Distal HLA-G Promoter Binds IFN-regulatory Factor 1 and Mediates Enhancement of This Nonclassical Class I Gene by IFN-beta
    Journal of Biological Chemistry, vol. 276, no. 9, pp. 6133–6139, 2001
  27. Behavioral alterations associated with apoptosis and down-regulation of presenilin 1 in the brains of p53-deficient mice
    Proceedings of the National Academy of Sciences, vol. 97, no. 10, pp. 5346–5350, 2000
  28. Heat shock and arsenite induce expression of the nonclassical class I histocompatibility HLA-G gene in tumor cell lines
    Cell Stress & Chaperones, vol. 5, no. 3, p. 207, 2000
  29. Implication of HLA-G molecule in heart-graft acceptance
    The Lancet, vol. 355, no. 9221, pp. 2138–2138, 2000
  30. Human Leukocyte Antigen-G: Immunotolerant Major Histocompatibility Complex Molecule in Transplantation
    World Journal of Surgery, vol. 24, no. 7, pp. 819–822, 2000
  31. A linkage disequilibrium map of the MHC region based on the analysis of 14 loci haplotypes in 50 French families
    European Journal of Human Genetics, vol. 8, no. 1, Article ID 5200391, 8 pages, 2000
  32. Microchimerism in human diseases
    Immunology Today, vol. 21, no. 3, pp. 116–118, 2000
  33. HLA-G, -E, -F preworkshop: tools and protocols for analysis of non-classical class I genes transcription and protein expression
    Human Immunology, vol. 61, no. 11, pp. 1177–1195, 2000
  34. Modulation of HLA-G expression in human thymic and amniotic epithelial cells
    Human Immunology, vol. 61, no. 11, pp. 1095–1101, 2000
  35. Analysis of the role of HLA-G in preeclampsia
    Human Immunology, vol. 61, no. 11, pp. 1126–1131, 2000
  36. HLA-G truncated isoforms can substitute for HLA-G1 in fetal survival
    Human Immunology, vol. 61, no. 11, pp. 1118–1125, 2000
  37. The X1 box of HLA-G promoter is a target site for RFX and Sp1 factors
    Human Immunology, vol. 61, no. 11, pp. 1132–1137, 2000
  38. Polymorphism of HLA-G gene and protein
    Journal of Reproductive Immunology, vol. 43, no. 2, pp. 105–109, 1999
  39. Role of HLA-G versus HLA-E on NK function: HLA-G is able to inhibit NK cytolysis by itself
    Journal of Reproductive Immunology, vol. 43, no. 2, pp. 175–182, 1999
  40. HLA-G inhibits the allogeneic proliferative response
    Journal of Reproductive Immunology, vol. 43, no. 2, pp. 203–211, 1999
  41. Molecular mechanisms controlling constitutive and IFN-?-inducible HLA-G expression in various cell types
    Journal of Reproductive Immunology, vol. 43, no. 2, pp. 213–224, 1999
  42. HLA-G expression in human melanoma cells: protection from NK cytolysis
    Journal of Reproductive Immunology, vol. 43, no. 2, pp. 183–193, 1999
  43. HLA-G: a tolerance molecule from the major histocompatibility complex
    Immunology Today, vol. 20, no. 2, pp. 60–62, 1999
  44. Role of HLA-G in maternal–fetal immune tolerance
    Transplantation Proceedings, vol. 31, no. 1-2, pp. 724–725, 1999
  45. HLA-G mediates protection from natural killer cytolysis: implications in immune tolerance
    Transplantation Proceedings, vol. 31, no. 1-2, pp. 1192–1193, 1999
  46. The HLA adventure
    Transplantation Proceedings, vol. 31, no. 1-2, pp. 22–24, 1999
  47. Immunotolerant functions of HLA-G
    Cellular and Molecular Life Sciences (CMLS), vol. 55, no. 3, pp. 327–333, 1999
  48. The immunotolerance role of HLA-G
    Seminars in Cancer Biology, vol. 9, no. 1, pp. 3–12, 1999
  49. HLA-G expression: immune privilege for tumour cells?
    Seminars in Cancer Biology, vol. 9, no. 1, pp. 27–36, 1999
  50. HLA-G: a new opening for HLA
    Seminars in Cancer Biology, vol. 9, no. 1, p. 1, 1999
  51. IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes
    International Immunology, vol. 11, no. 5, pp. 803–811, 1999
  52. HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes
    International Immunology, vol. 11, no. 8, pp. 1351–1356, 1999
  53. SIAH-1 promotes apoptosis and tumor suppression through a network involving the regulation of protein folding, unfolding, and trafficking: Identification of common effectors with p53 and p21Waf1
    Proceedings of the National Academy of Sciences, vol. 96, no. 14, pp. 8070–8073, 1999
  54. Downregulation of HLA Class I Gene Transcription in Choriocarcinoma Cells is Controlled by the Proximal Promoter Element and Can be Reversed by CIITA
    Placenta, vol. 20, no. 4, pp. 293–301, 1999
  55. Transplacental Transmission of Natural-Killer-Cell Lymphoma
    New England Journal of Medicine, vol. 341, no. 25, pp. 1937–1937, 1999
  56. p21WAF-1 reorganizes the nucleus in tumor suppression
    Proceedings of the National Academy of Sciences, vol. 95, no. 3, pp. 1131–1135, 1998
  57. HLA-G expression in melanoma: A way for tumor cells to escape from immunosurveillance
    Proceedings of the National Academy of Sciences, vol. 95, no. 8, pp. 4510–4515, 1998
  58. Chimerism in scleroderma
    The Lancet, vol. 351, no. 9119, pp. 1886–1886, 1998
  59. Fetal DNA in skin of polymorphic eruptions of pregnancy
    The Lancet, vol. 352, no. 9144, pp. 1898–1901, 1998
  60. Specific binding of nuclear factors to the HLA-G gene promoter correlates with a lack of HLA-G transcripts in first trimester human fetal liver
    Human Immunology, vol. 59, no. 12, pp. 751–757, 1998
  61. Inhibition of presenilin 1 expression is promoted by p53 and p21WAF-1 and results in apoptosis and tumor suppression
    Nature Medicine, vol. 4, no. 7, Article ID nm0798-835, 3 pages, 1998
  62. Tolérance fœtomaternelle : rôle de la molécule HLA-G dans la protection du fœtus contre l'activité natural killer maternelleFetal-maternal tolerance: role of HLA-G in protection of the fetus against maternal natural killer cell activity
    Comptes Rendus de l'Académie des Sciences - Series III - Sciences de la Vie, vol. 320, no. 5, pp. 385–392, 1997
  63. Search for DNA sequence variations using a MutS-based technology
    Mutation Research/Mutation Research Genomics, vol. 382, no. 1-2, pp. 35–43, 1997
  64. HLA-G Gene Transcriptional Regulation in Trophoblasts and Blood CellsDifferential Binding of Nuclear Factors to a Regulatory Element Located 1.1 kb from Exon 1
    Human Immunology, vol. 52, no. 1, pp. 41–46, 1997
  65. HLA-G gene polymorphism segregation within CEPH reference families
    Human Immunology, vol. 53, no. 2, pp. 140–147, 1997
  66. Exhaustive screening of the 21-hydroxylase gene in a population of hyperandrogenic women
    Human Genetics, vol. 101, no. 1, pp. 56–60, 1997
  67. The alpha 1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: Is HLA-G the public ligand for natural killer cell inhibitory receptors?
    Proceedings of the National Academy of Sciences, vol. 94, no. 10, pp. 5249–5254, 1997
  68. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis
    Proceedings of the National Academy of Sciences, vol. 94, no. 21, pp. 11520–11525, 1997
  69. Activation of the human homologue of the Drosophila sina gene in apoptosis and tumor suppression
    Proceedings of the National Academy of Sciences, vol. 93, no. 17, pp. 9039–9042, 1996
  70. Isolation of 10 differentially expressed cDNAs in p53-induced apoptosis: Activation of the vertebrate homologue of the Drosophila seven in absentia gene
    Proceedings of the National Academy of Sciences, vol. 93, no. 9, pp. 3953–3957, 1996
  71. Survey of CAG/CTG repeats in human cDNAs representing new genes: candidates for inherited neurological disorders
    Human Molecular Genetics, vol. 5, no. 7, pp. 1001–1009, 1996
  72. HLA-G revisited
    Immunology Today, vol. 17, no. 9, pp. 407–409, 1996
  73. Evidence for the Presence of the Alternatively Spliced HLA-G mRNA Forms in Human Mononuclear Cells from Peripheral Blood and Umbilical Cord Blood
    Human Immunology, vol. 43, no. 3, pp. 237–241, 1995
  74. Soluble HLA-G Molecule An Alternatively Spliced HLA-G mRNA Form Candidate to Encode It in Peripheral Blood Mononuclear Cells and Human Trophoblasts
    Human Immunology, vol. 43, no. 3, pp. 231–236, 1995
  75. Detection of Membrane-Bound HLA-G Translated Products with a Specific Monoclonal Antibody
    Proceedings of the National Academy of Sciences, vol. 92, no. 22, pp. 10292–10296, 1995
  76. An Alternatively Spliced Form of HLA-G mRNA in Human Trophoblasts and Evidence for the Presence of HLA-G Transcript in Adult Lymphocytes
    Proceedings of the National Academy of Sciences, vol. 91, no. 10, pp. 4209–4213, 1994
  77. Cloning the Human Major Histocompatibility Complex in YACs
    Genomics, vol. 23, no. 3, pp. 520–527, 1994
  78. Dense Alu clustering and a potential new member of the NF?B family within a 90 kilobase HLA Class III segment
    Nature Genetics, vol. 3, no. 2, Article ID ng0293-137, 8 pages, 1993
  79. Genetic mapping of three human homologues of murine t-complex genes localizes TCP10 to 6q27, 15 cM distal to TCP1 and PLG
    Genomics, vol. 12, no. 4, pp. 826–828, 1992
  80. Altered Binding of Regulatory Factors to HLA Class I Enhancer Sequence in Human Tumor Cell Lines Lacking Class I Antigen Expression
    Proceedings of the National Academy of Sciences, vol. 89, no. 8, pp. 3488–3492, 1992
  81. HLA Class I Molecules are Associated with CD1a Heavy Chains on Normal Human Thymus Cells
    Proceedings of the National Academy of Sciences, vol. 85, no. 12, pp. 4451–4454, 1988
  82. Use of a Variable alpha Region to Create a Functional T-Cell Receptor delta Chain
    Proceedings of the National Academy of Sciences, vol. 85, no. 15, pp. 5634–5638, 1988
  83. HLA-DQ Rather Than HLA-DR Region Might Be Involved in Dominant Nonsusceptibility to Diabetes
    Proceedings of the National Academy of Sciences, vol. 85, no. 17, pp. 6473–6477, 1988
  84. Use of Synthetic Oligonucleotides for Genomic DNA Dot Hybridization to Split the DQw3 Haplotype
    Proceedings of the National Academy of Sciences, vol. 85, no. 8, pp. 2682–2685, 1988
  85. The V gamma locus of the human T cell receptor gamma gene. Repertoire polymorphism of the first variable gene segment subgroup
    Journal of Experimental Medicine, vol. 168, no. 4, pp. 1383–1394, 1988
  86. The required interaction between monocytes and peripheral blood T lymphocytes (T-PBL) upon activation via CD2 or CD3. Role of HLA class I molecules from accessory cells and the differential response of T-PBL subsets
    European Journal of Immunology, vol. 18, no. 8, pp. 1187–1194, 1988
  87. Role in T-Cell Activation for HLA Class I Molecules from Accessory Cells: Further Distinction between Activation Signals Delivered to T Cells Via CD2 and CD3 Molecules
    Proceedings of the National Academy of Sciences, vol. 84, no. 20, pp. 7222–7226, 1987
  88. Human T cell gamma genes are frequently rearranged in B-lineage acute lymphoblastic leukemias but not in chronic B cell proliferations
    Journal of Experimental Medicine, vol. 165, no. 4, pp. 1000–1015, 1987
  89. Two DR  Allelic Series Defined by Exon II-Specific Synthetic Oligonucleotide Genomic Hybridization: A Method of HLA Typing?
    Proceedings of the National Academy of Sciences, vol. 83, no. 20, pp. 7836–7840, 1986
  90. A study of the HLA-D region in patients with classic Kaposi's sarcoma
    Immunogenetics, vol. 24, no. 2, pp. 115–117, 1986
  91. Human autologous rosette-forming cells. V. Study of MHC control in erythrocyte-lymphocyte interaction
    Human Immunology, vol. 16, no. 1, pp. 81–90, 1986
  92. Relationship between postvaccinal anti-influenza antibodies, blood magnesium levels, and HLA antigens
    Human Immunology, vol. 12, no. 1, pp. 1–8, 1985
  93. Role of H-2 and non-H-2 genes in the control of blood magnesium levels
    Immunogenetics, vol. 19, no. 5, pp. 435–448, 1984
  94. The Heterogeneity and Functional Capacities of Human Thymocyte Subpopulations
    Proceedings of the National Academy of Sciences, vol. 81, no. 15, pp. 4912–4916, 1984
  95. THE DURATION OF DONOR-SPECIFIC HYPERSENSITIVITY AFTER HUMAN ALLOGRAFT REJECTION
    Transplantation, vol. 36, no. 4, p. 456, 1983
  96. HLA and Susceptibility to Hodgkin's Disease
    Immunological Reviews, vol. 70, no. 1, pp. 167–192, 1983
  97. HLA- and Gm-linked genes affecting the degradation rate of antigens (sheep red blood cells) endocytized by macrophages
    Human Immunology, vol. 4, no. 1, pp. 1–13, 1982
  98. Is the MHC a general self-recognition system playing a major unifying role in an organism?
    Human Immunology, vol. 1, no. 1, pp. 5–17, 1980
  99. The challenge of the early days of human histocompatibility
    Immunogenetics, vol. 10, no. 1-4, pp. 1–5, 1980
  100. HLA-DR specific human suppressor lymphocytes generated by repeated in vitro sensitisation against allogeneic cells
    Nature, vol. 276, no. 5687, Article ID 276502a0, 2 pages, 1978
  101. Le complexe HLA considéré comme une unité immunologique
    Revue Francaise de Transfusion et Immuno-hématologie, vol. 20, no. 1, pp. 15–18, 1977
  102. Greffe de moelle osseuse dans les aplasies médullaires
    Revue Francaise de Transfusion et Immuno-hématologie, vol. 20, no. 1, pp. 61–63, 1977
  103. AUTOLYMPHOCYTOTOXIC ANTIBODIES AFTER BONE-MARROW TRANSPLANTATION
    The Lancet, vol. 310, no. 8029, pp. 146–147, 1977
  104. Induction of HLA expression in Daudi cells after cell fusion
    Immunogenetics, vol. 5, no. 1, pp. 423–436, 1977
  105. HLA markers and lymphocytotoxins in lichen planus
    Archives of Dermatology, vol. 113, no. 12, pp. 1719–1720, 1977
  106. The Study of Human Ia-Like Specificities Using Antibody Eluates from Human Lymphoblastoid Cell Lines
    Scandinavian Journal of Immunology, vol. 6, no. 5, pp. 409–412, 1977
  107. Specificities shared between HLA-A3 and HLA-A11 detected by Fab'2 blocking
    Immunogenetics, vol. 3, no. 1, pp. 233–240, 1976
  108. Mixed lymphocyte reactivity of human lymphocytes primedin vitro. I. Secondary response to allogenic lymphocytes
    European Journal of Immunology, vol. 5, no. 5, pp. 295–301, 1975
  109. Some Contributions of the HL-A Complex to the Genetics of Human Diseases
    Immunological Reviews, vol. 22, no. 1, pp. 44–74, 1975
  110. A QUANTITATIVE EVALUATION OF HL-A GENE PRODUCTS
    Transplantation, vol. 17, no. 4, pp. 427–429, 1974
  111. Human migrations and linkage disequilibrium ofHL-A system
    Immunogenetics, vol. 1, no. 1, pp. 195–210, 1974
  112. The association of the HL-A antigens with diseases
    Clinical Immunology and Immunopathology, vol. 3, no. 1, pp. 127–149, 1974
  113. HISTOCOMPATIBILITY DETERMINANTS IN MULTIPLE SCLEROSIS
    The Lancet, vol. 303, no. 7852, pp. 307–308, 1974
  114. NON-COMPLEMENT-FIXING IgM ANTIBODIES WITH ANTI-HL-A2 SPECIFICITY AND BLOCKING ACTIVITY
    Transplantation, vol. 16, no. 3, pp. 257–260, 1973
  115. Antibody-induced redistribution of HL-A antigens at the cell surface
    European Journal of Immunology, vol. 2, no. 3, pp. 249–257, 1972
  116. Depression of immunologic reactivity of patients with acute leukemia
    Cancer, vol. 27, no. 2, pp. 323–331, 1971
  117. CRITICAL EVALUATION OF HISTOCOMPATIBILITY IN 179 RENAL TRANSPLANTS
    The Lancet, vol. 297, no. 7700, pp. 609–612, 1971
  118. HISTOCOMPATIBILITY STUDIES IN A CLOSELY BRED COLONY OF DOGS: II. INFLUENCE OF THE DL-A SYSTEM OF CANINE HISTOCOMPATIBILITY UPON THE SURVIVAL OF CARDIAC ALLOGRAFTS
    Journal of Experimental Medicine, vol. 133, no. 2, pp. 260–274, 1971
  119. HISTOCOMPATIBILITY STUDIES IN A CLOSELY BRED COLONY OF DOGS: III. GENETIC DEFINITION OF THE DL-A SYSTEM OF CANINE HISTOCOMPATIBILITY, WITH PARTICULAR REFERENCE TO THE COMPARATIVE IMMUNOGENICITY OF THE MAJOR TRANSPLANTABLE ORGANS
    Journal of Experimental Medicine, vol. 134, no. 5, pp. 1222–1237, 1971
  120. A STUDY OF HL-A ANTIGENS IN HUMAN ORGANS
    Transplantation, vol. 9, no. 3, pp. 185–192, 1970
  121. SEPARATION OF HL-A TRANSPLANTATION ANTIGEN SPECIFICITIES
    Transplantation, vol. 9, no. 3, pp. 228–239, 1970
  122. Probable Haploid Expression of HL-A Antigens on Human Spermatozoon
    Nature, vol. 225, no. 5228, Article ID 225191a0, 2 pages, 1970
  123. Immunological principles of donor selection for human cardiac transplantation
    Progress in Cardiovascular Diseases, vol. 12, no. 2, pp. 119–143, 1969
  124. RETROSPECTIVE LEUKOCYTE TYPING OF UNRELATED HUMAN DONOR-RECIPIENT PAIRS IN RELATION TO SKIN ALLOGRAFT SURVIVAL TIMES
    Transplantation, vol. 7, no. 3, pp. 188–193, 1969
  125. RELATION OF ANTIGENS Da6 AND 6b (Da9) WITH THE ANTIGENS OF THE SECOND SUBLOCUS OF THE HL-A SYSTEM
    Transplantation, vol. 8, no. 5, p. 739, 1969
  126. Human HL-A transplantation antigens: Separation of molecules carrying different immunological specificities determined by a single genotype
    Biochemical and Biophysical Research Communications, vol. 33, no. 1, pp. 88–93, 1968
  127. Lymphocyte Stimulation by Soluble Human HL-A Transplantation Antigens
    Nature, vol. 219, no. 5155, Article ID 219704a0, 2 pages, 1968
  128. Role of ABO Erthrocyte Groups in Human Histocompatibility Reactions
    Nature, vol. 209, no. 5019, Article ID 209209a0, 2 pages, 1966